Amylyx Pharmaceuticals (AMLX) Receivables - Accured (2022 - 2026)
Amylyx Pharmaceuticals (AMLX) reported Receivables - Accured of $500,000 for Q2 2026, up 400.0% from $100,000 a year earlier and up 400.0% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Receivables - Accured (2022 - 2026) Analysis & Trends
At the end of FY2025, Amylyx Pharmaceuticals posted Receivables - Accured of $100,000, unchanged from FY2024.
- Receivables - Accured has a three-year compound annual growth rate of -41.5% (FY2022 to FY2025).
- By year, Receivables - Accured came in at $100,000 in FY2024 (-80.0%), $500,000 in FY2023 (unchanged) and $500,000 in FY2022.
- Five-year quarterly Receivables - Accured spans a low of $100,000 in Q3 2023 and a high of $800,000 in Q2 2023.
- Year over year, Receivables - Accured gained in 1 of the last eight quarters, with growth averaging 31.7%.
- The high point for year-over-year Receivables - Accured in five years was Q2 2026 (growth of 400.0%); the low point was Q2 2024 (a decline of 87.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $100,000 (Q1 2026), $100,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | 500,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 500,000.00 |
API Access
Amylyx Pharmaceuticals Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();